- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.09.24 | Enzolytics, Inc.: Bulgarian Academy of Sciences Issues Report on Results of Its In Vivo Testing of IPF as an Immunomodulator | 345 | ACCESS Newswire | FIRST COLLABORATIVE EFFORT UNDER NEW AGREEMENT ALLEN, TX / ACCESSWIRE / September 18, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com") (the "Company") announced today that the Department of... ► Artikel lesen | |
| 09.09.24 | Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences and Enzolytics, Inc. Execute Three Year Agreement | 494 | ACCESS Newswire | ALLEN, TX / ACCESSWIRE / September 9, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com") (the "Company") announced today that the Company and the Stephan Angeloff Institute of Microbiology,... ► Artikel lesen | |
| 20.08.24 | Enzolytics, Inc.: Final Report From the National Centre of Infectious and Parasitic Diseases Concludes Lyophilized Pepsin Significantly Reduces the Survival and Proliferation of Growth in Specific Cancer Cells | 352 | ACCESS Newswire | ALLEN, TX / ACCESSWIRE / August 20, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com") (the "Company") announced today that a study conducted at the Ministry of Health National Centre of Infectious... ► Artikel lesen | |
| 31.07.24 | Enzolytics, Inc. and the Bulgarian Academy of Sciences Initiate a Cooperative Program Primarily Focusing on Applied and Strategic Research in Immunology for Cancer and HIV/AIDS Applications | 489 | ACCESS Newswire | As well as Diabetes, Multiple Sclerosis and Other Diseases ALLEN, TX / ACCESSWIRE / July 31, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com") (the "Company") announced today that the Company... ► Artikel lesen | |
| 29.07.24 | Enzolytics, Inc. Enters Into Collaboration Agreement With Manufacturer Elimus Ltd. | 265 | ACCESS Newswire | Updates on Results of Litigation ALLEN, TX / ACCESSWIRE / July 29, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com")(the "Company") announced today that it has entered into a 4 year Collaboration... ► Artikel lesen | |
| 26.07.24 | Enzolytics, Inc.: Enzolytics Inc. Supports Sagaliam Acquisition Corp Response to Competitors False and Misleading Press Release | 604 | ACCESS Newswire | ALLEN, TX / ACCESSWIRE / July 26, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) (enzolytics.com) (the "Company") stated today that the Company will whole heartedly support any and all efforts by Sagaliam... ► Artikel lesen | |
| 01.07.24 | Enzolytics, Inc. Enters Into Exclusive Worldwide License for Patented Immunotherapy Cancer Treatment | 320 | ACCESS Newswire | Update on Sagaliam Acquisition Corp. ALLEN, TX / ACCESSWIRE / July 1, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com") (the "Company") announced today that the Company is entering into a worldwide... ► Artikel lesen | |
| 03.06.24 | Enzolytics, Inc. Poised to Invest Alongside Sagaliam Acquisition Corp in Revolutionary Room Temperature SPAD Technology | 412 | ACCESS Newswire | ALLEN, TX / ACCESSWIRE / June 3, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com")(the "Company") is thrilled to announce that the Company and Sagaliam Acquisition Corp ("SAGA") are negotiating... ► Artikel lesen | |
| ENZOLYTICS Aktie jetzt für 0€ handeln | |||||
| 22.05.24 | Enzolytics, Inc. Announces Letter of Intent for Exclusive Licensing Agreement for Patented Nitric Oxide Formulation | 404 | ACCESS Newswire | Updates on ETC Marketing, Inc and Ownership of ITV-1 and IPFALLEN, TX / ACCESSWIRE / May 22, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com")(the "Company") announced today that it has entered... ► Artikel lesen | |
| 02.05.24 | Enzolytics, Inc. Announces Formation of Marketing Company in Partnership with Third Coast Fulfillment | 354 | ACCESS Newswire | ALLEN, TX / ACCESSWIRE / May 2, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) (the "Company") announced today the plan to form ETC Marketing Inc. ("ETC Marketing") in partnership with Third Coast Fulfillment... ► Artikel lesen | |
| 26.04.24 | Sagaliam Acquisition Corp. Announces Novation Agreement with Enzolytics, Inc. | 608 | ACCESS Newswire | NEW YORK, NY / ACCESSWIRE / April 26, 2024 / Sagaliam Acquisition Corp. ("SAGAU", "SAGA", SAGAR") (the "Company") announced that Sagaliam entered into a Novation Agreement with Enzolytics, Inc. (OTC... ► Artikel lesen | |
| 23.04.24 | Enzolytics, Inc.: Enzolytics Inc. Announces Dismissal of The Dimitar Savov Lawsuit in Nevada | 364 | ACCESS Newswire | Offers Update on OTC Annual Report and Business Model ALLEN, TX / ACCESSWIRE / April 23, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) (enzolytics.com)(the "Company") today disclosed that on April 9, 2024... ► Artikel lesen | |
| 12.04.24 | Enzolytics, Inc.: Update on Formulation of New Business Strategy | 497 | ACCESS Newswire | INFORMATION ON ENZOLYTICS, INC.BOARD OF DIRECTORS AND CHIEF EXECUTIVE OFFICERUPDATE ON FORMULATION OF NEW BUSINESS STRATEGYALLEN, TX / ACCESSWIRE / April 12, 2024 / Enzolytics, Inc. (OTC PINK:ENZC)... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 36,510 | -1,46 % | Qiagen NV-Aktie läuft heute schlechter (36,415 €) | Im Minus liegt aktuell das Wertpapier von Qiagen NV . Das Papier kostete zuletzt 36,42 Euro. Die Qiagen NV-Aktie verzeichnet gegenwärtig ein Minus von 1,29 Prozent. Sie hat sich um 48 Cent gegenüber... ► Artikel lesen | |
| EVOTEC | 6,595 | -2,01 % | DEUTSCHE BANK RESEARCH stuft Evotec auf 'Sell' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Evotec vor Zahlen mit einem Kursziel von 4 Euro auf "Sell" belassen. Der Wirkstoffforscher dürfte ein Umsatzplus von 11 Prozent... ► Artikel lesen | |
| TEMPUS AI | 49,050 | +0,39 % | Tempus AI, Inc. (TEM): Among The Stocks With At Least $10 Million In Insider Sales Recently | ||
| BIONTECH | 101,60 | -2,40 % | Novo Nordisk, NetraMark, BioNTech - Wie drei Pioniere den Weg in die Medizin von morgen ebnen | Am 6. Januar 2025 hat die FDA neue Richtlinien für KI-gestützte klinische Studien ankündigt, um die Zulassung lebensrettender Therapien zu beschleunigen. Damit rücken Unternehmen in den Fokus, die Technologie... ► Artikel lesen | |
| SPRINGWORKS THERAPEUTICS | 49,500 | -3,55 % | Check Out What Whales Are Doing With SWTX | ||
| MODERNA | 34,185 | +6,89 % | Opening Bell: Bitcoin, BYD, Tesla, GM, Best Buy, Crowdstrike, Fook Locker, Abercrombie, Moderna | Die anhaltenden Zollstreitigkeiten der USA mit ihren wichtigsten Handelspartnern setzen die Aktienmärkte gestern erneut unter Druck und schüren Nervosität unter den Anlegern. Der Dow Jones schloss mit... ► Artikel lesen | |
| DOGWOOD THERAPEUTICS | 6,630 | +49,66 % | Pre-market Movers: Allurion Technologies, Nvni Group, Dogwood Therapeutics, Jupiter Neurosciences, Ctrl Group | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.15 A.M. ET).In the Green Allurion Technologies Inc. (ALUR) is up over 297%... ► Artikel lesen | |
| EDGEWISE THERAPEUTICS | 28,000 | -0,46 % | Scotiabank sets $50 target for Edgewise Therapeutics stock | ||
| RECURSION PHARMACEUTICALS | 6,595 | +5,69 % | This Is What Whales Are Betting On Recursion Pharmaceuticals | ||
| KEROS THERAPEUTICS | 11,380 | -4,69 % | Keros Therapeutics, Inc.: Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results | LEXINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ("Keros" or the "Company") (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 17,780 | -6,37 % | Summit Therapeutics Inc. (SMMT): Why Are Analysts Bullish On This Hot Growth Stock Right Now? | ||
| LENZ THERAPEUTICS | 23,680 | +4,00 % | LENZ Therapeutics, Inc.: LENZ Therapeutics Reports Third Quarter 2024 Financial Results | New Drug Application (NDA) for LNZ100 for treatment of presbyopia accepted for review by the U.S. Food and Drug Administration (FDA); PDUFA target action date of August 8, 2025 CORXEL and... ► Artikel lesen | |
| STRYKER | 350,60 | +0,26 % | Stryker Unveils Steri-Shield 8 Personal Protection System To Boost Safety, Comfort | WASHINGTON (dpa-AFX) - Stryker Corp. (SYK), a medical technology company, Tuesday announced that it has introduced the Steri-Shield 8 personal protection system, the latest addition to its personal... ► Artikel lesen | |
| APOGEE THERAPEUTICS | 36,280 | +2,20 % | Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2024 Financial Results | Accelerated execution of Phase 2 APEX clinical trial for APG777, with Part A over-enrolled and Part B initiated ahead of schedule; topline Part A 16-week data expected mid-2025 APG279 (APG777 + APG990)... ► Artikel lesen | |
| ADMA BIOLOGICS | 17,010 | +0,59 % | ADMA Biologics, Inc.: ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update | FY 2024 Total Revenue of $426.5 Million, a 65% YoY Increase FY 2024 GAAP Net Income of $197.7 Million, Including an $84.3 Million Valuation Allowance Tax Benefit FY 2024 Adjusted EBITDA(1)... ► Artikel lesen |
Das Unternehmen ENZOLYTICS INC kann der Branche Biotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENZOLYTICS INC finden Sie auf Wallstreet Online.
